Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Standardized Cat Hair Allergenic Extract is a sterile solution containing allergens derived from the hair of the domestic cat (Felis catus). The primary active component is Fel d 1, the major cat allergen. The product is used for both diagnostic skin testing and subcutaneous immunotherapy in patients with a history of allergy to cats. It works by inducing immune tolerance to specific allergens through controlled exposure, thereby reducing allergic symptoms such as asthma, rhinitis, and conjunctivitis upon subsequent natural exposure. The potency of the extract is measured in Bioequivalent Allergy Units per milliliter (BAU/mL), based on Fel d 1 content and quantitative skin testing. Standardized Cat Hair Allergenic Extract has been approved since 1992 for these uses[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Standardized allergenic extract, cat hair.